EUVIMEDOpdag EUVIMED
Crossref

Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone

M Katano, F Nagumo, E Kubota, H Yamamoto, T Matsuo, T Hisatsugu, J Tadano

Biotherapy · 1993

DOI: 10.1007/bf01877383 ↗

At a glance

Journal article in Biotherapy, 1993. Written by M Katano and 6 co-authors. Institution: Department of Surgery, Saga Medical School, Japan. Cited 4 times so far (Crossref); 25 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

MeSH terms (MEDLINE)

AgedAntigens, SurfaceAscitic FluidCD8 AntigensClone CellsCytokinesCytotoxicity, ImmunologicHumansInterleukin-2KineticsLymphocyte ActivationLymphocytes, Tumor-InfiltratingMalePancreatic NeoplasmsPhenotypeRecombinant ProteinsT-Lymphocytes, CytotoxicTumor Cells, Cultured

Substances

Antigens, SurfaceCD8 AntigensCytokinesInterleukin-2Recombinant Proteins

Authors and institutions

  • Department of Surgery, Saga Medical School, Japan.

Cite

APA

Katano, M., Nagumo, F., Kubota, E., Yamamoto, H., Matsuo, T., Hisatsugu, T., & Tadano, J. (1993). Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone. Biotherapy. https://doi.org/10.1007/bf01877383

Vancouver

Katano M, Nagumo F, Kubota E, Yamamoto H, Matsuo T, Hisatsugu T, et al. Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone. Biotherapy. 1993. doi:10.1007/bf01877383

BibTeX
@article{Katano1993,
  author = {Katano, M and Nagumo, F and Kubota, E and Yamamoto, H and Matsuo, T and Hisatsugu, T and Tadano, J},
  title = {Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone},
  journal = {Biotherapy},
  year = {1993},
  doi = {10.1007/bf01877383}
}
Start for free →